Most cited papers from Nevada Cancer Research Foundation
Nevada Cancer Research Foundation
What are the most cited papers from Nevada Cancer Research Foundation?
The most cited paper from Nevada Cancer Research Foundation is "Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial" (Manish R. Patel, John Allan Ellerton, Jeffrey R. Infante et al., 2017), with 591 citations. Next come "Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma" (582) and "Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies" (252).
Showing 15 of 15 papers.Every paper is listed.
Most cited papers, sortable by citations and release date
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or
Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation;
retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown.
How the lists are chosen.